Fluotracen

Fluotracen
Skeletal formula of fluotracen
Ball-and-stick model of the fluotracen molecule
Systematic (IUPAC) name
N,N-dimethyl-3-[10-methyl-2-(trifluoromethyl)-9,10-dihydroanthracen-9-yl]propan-1-amine
Clinical data
Legal status
  • Uncontrolled
Routes of
administration		 Oral
Identifiers
CAS Number 35764-73-9
57363-14-1 (HCl)
ATC code None
PubChem CID 42291
ChemSpider 38565
UNII 3026WKR55S YesY
Chemical data
Formula C21H24F3N
Molar mass 347.42 g/mol

Fluotracen (SKF-28,175) is a tricyclic drug which possesses dual antidepressant and antipsychotic activity.[1][2][3] This profile of effects is similar to that of related agents like amoxapine, loxapine, and trimipramine which may also be used in the treatment of both depression and psychosis.[1] It was believed that such duality would be advantageous in the treatment of schizophrenia, as depression is often comorbid with the disorder (i.e., negative symptoms), and usual antipsychotics often worsen such symptoms.[1] In any case, however, fluotracen was never marketed.[3]

See also

References

  1. 1 2 3 Annual Reports in Medicinal Chemistry: v. 14. Academic Press Inc.,U.S. 1979. ISBN 0-12-040514-8.
  2. ↑ Fowler PJ, Zirkle CL, Macko E; et al. (1977). "Fluotracen: a tricyclic compound with the combined properties of antidepressants and antipsychotics in animals". Arzneimittel-Forschung 27 (8): 1589–95. PMID 410422.
  3. 1 2 David J. Triggle (1996). Dictionary of Pharmacological Agents. Boca Raton: Chapman & Hall/CRC. ISBN 0-412-46630-9.
This article is issued from Wikipedia - version of the Sunday, May 24, 2015. The text is available under the Creative Commons Attribution/Share Alike but additional terms may apply for the media files.